Please login to the form below

Not currently logged in
Email:
Password:

genital herpes

This page shows the latest genital herpes news and features for those working in and with pharma, biotech and healthcare.

Genital herpes vaccine candidate promising in phase II

Genital herpes vaccine candidate promising in phase II

A vaccine that could free patients with genital herpes from lifelong drug treatment to control outbreaks has shown promise in a phase II trial. ... The vaccine - called GEN-003 and developed by Genocea Biosciences - is a T cell-enabled therapeutic

Latest news

  • Vical's genital herpes vaccine flunks trial Vical's genital herpes vaccine flunks trial

    Vical admitted yesterday that two versions of its genital herpes vaccine failed to meet their objectives in a phase III trial, throwing the future of the programme into doubt. ... to reduce virus shedding in patients with genital herpes in the phase I/II

  • Sanofi to work with Immune Design on herpes vaccine Sanofi to work with Immune Design on herpes vaccine

    Sanofi has joined forces with US biotech Immune Design to accelerate development of the first therapeutic vaccine against genital herpes. ... Sanofi notes that genital herpes is the most common STI and affects around one in six people in the US, with

  • Medivir and Meda in Xerese renegotiation

    Medivir has renegotiated the terms of its financial arrangement with Meda for Xerese, its marketed product for herpes labialis, in North America. ... The agreement also provides Meda with the exclusive US rights to Xerese for the genital herpes indication

  • FDA cracks down on bogus STD drugs

    The two federal agencies are targeting products that make unproven claims to treat, cure, and prevent STDs including herpes, chlamydia, genital warts, HIV and AIDS. ... and proven herpes killers in a single formula"; and Viruxo, which is sold on a

  • Valeant acquires GSK's Zovirax

    Valeant Pharmaceuticals' Biovail Laboratories has signed a deal under which it will acquire all US and Canadian rights to non-ophthalmic topical formulations of GlaxoSmithKline's (GSK) herpes drug Zovirax (acyclovir) ... Zovirax ointment and cream are

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics